Imaging assessment of bioresorbable vascular scaffolds

Yohei Sotomi; Pannipa Suwannasom; Erhan Tenekecioglu; Carlos Collet; Shimpei Nakatani; Takayuki Okamura; Takashi Muramatsu; Yuki Ishibashi; Hiroki Tateishi; Yosuke Miyazaki; Taku Asano; Yuki Katagiri; Constantin von zur Muehlen; Kengo Tanabe; Ken Kozuma; Yukio Ozaki; Patrick W. Serruys; Yoshinobu Onuma

doi:10.1007/s12928-017-0486-5

Imaging assessment of bioresorbable vascular scaffolds

Yohei Sotomi, Pannipa Suwannasom, Erhan Tenekecioglu, Carlos Collet, Shimpei Nakatani, Takayuki Okamura, Takashi Muramatsu, Yuki Ishibashi, Hiroki Tateishi, Yosuke Miyazaki, Taku Asano, Yuki Katagiri, Constantin von zur Muehlen, Kengo Tanabe, Ken Kozuma, Yukio Ozaki, Patrick W. Serruys, Yoshinobu Onuma

Division of Cardiology

Research output: Contribution to journal › Review article › peer-review

9 Citations (Scopus)

Abstract

Vascular reparative therapy has become a reality with bioresorbable scaffolds (BRSs). To assess acute and long-term performance of the device, multimodality imaging would be essential. Radiopacity of metal hinders the imaging assessment, whereas radiolucent polymeric scaffolds allow for a precise imaging assessment with either invasive or non-invasive modality at baseline and at follow-up, which is one of the advantages of polymeric BRSs. Recent large trials evaluating clinical results of the first-generation BRS technology raised concerns about the safety and efficacy of these devices, namely, scaffold thrombosis. Intensive research with multimodality imaging in the field is being conducted to have in-depth understanding of the issues, which will facilitate the improvement of implantation techniques and the development of the next-generation BRSs. The current review focuses on the clinical application of the imaging modalities to assess the short- and long-term performance of the Absorb BVS.

Original language	English
Pages (from-to)	11-22
Number of pages	12
Journal	Cardiovascular Intervention and Therapeutics
Volume	33
Issue number	1
DOIs	https://doi.org/10.1007/s12928-017-0486-5
Publication status	Published - 01-01-2018

All Science Journal Classification (ASJC) codes

Radiology Nuclear Medicine and imaging
Cardiology and Cardiovascular Medicine

Access to Document

10.1007/s12928-017-0486-5

Cite this

Sotomi, Y., Suwannasom, P., Tenekecioglu, E., Collet, C., Nakatani, S., Okamura, T., Muramatsu, T., Ishibashi, Y., Tateishi, H., Miyazaki, Y., Asano, T., Katagiri, Y., von zur Muehlen, C., Tanabe, K., Kozuma, K., Ozaki, Y., Serruys, P. W., & Onuma, Y. (2018). Imaging assessment of bioresorbable vascular scaffolds. Cardiovascular Intervention and Therapeutics, 33(1), 11-22. https://doi.org/10.1007/s12928-017-0486-5

@article{6fdb5028cd174197898b4dc2f8b1872a,

title = "Imaging assessment of bioresorbable vascular scaffolds",

abstract = "Vascular reparative therapy has become a reality with bioresorbable scaffolds (BRSs). To assess acute and long-term performance of the device, multimodality imaging would be essential. Radiopacity of metal hinders the imaging assessment, whereas radiolucent polymeric scaffolds allow for a precise imaging assessment with either invasive or non-invasive modality at baseline and at follow-up, which is one of the advantages of polymeric BRSs. Recent large trials evaluating clinical results of the first-generation BRS technology raised concerns about the safety and efficacy of these devices, namely, scaffold thrombosis. Intensive research with multimodality imaging in the field is being conducted to have in-depth understanding of the issues, which will facilitate the improvement of implantation techniques and the development of the next-generation BRSs. The current review focuses on the clinical application of the imaging modalities to assess the short- and long-term performance of the Absorb BVS.",

author = "Yohei Sotomi and Pannipa Suwannasom and Erhan Tenekecioglu and Carlos Collet and Shimpei Nakatani and Takayuki Okamura and Takashi Muramatsu and Yuki Ishibashi and Hiroki Tateishi and Yosuke Miyazaki and Taku Asano and Yuki Katagiri and {von zur Muehlen}, Constantin and Kengo Tanabe and Ken Kozuma and Yukio Ozaki and Serruys, {Patrick W.} and Yoshinobu Onuma",

note = "Publisher Copyright: {\textcopyright} 2017, Japanese Association of Cardiovascular Intervention and Therapeutics.",

year = "2018",

month = jan,

day = "1",

doi = "10.1007/s12928-017-0486-5",

language = "English",

volume = "33",

pages = "11--22",

journal = "Cardiovascular Intervention and Therapeutics",

issn = "1868-4300",

publisher = "Springer Verlag",

number = "1",

}

Sotomi, Y, Suwannasom, P, Tenekecioglu, E, Collet, C, Nakatani, S, Okamura, T, Muramatsu, T, Ishibashi, Y, Tateishi, H, Miyazaki, Y, Asano, T, Katagiri, Y, von zur Muehlen, C, Tanabe, K, Kozuma, K, Ozaki, Y, Serruys, PW & Onuma, Y 2018, 'Imaging assessment of bioresorbable vascular scaffolds', Cardiovascular Intervention and Therapeutics, vol. 33, no. 1, pp. 11-22. https://doi.org/10.1007/s12928-017-0486-5

TY - JOUR

T1 - Imaging assessment of bioresorbable vascular scaffolds

AU - Sotomi, Yohei

AU - Suwannasom, Pannipa

AU - Tenekecioglu, Erhan

AU - Collet, Carlos

AU - Nakatani, Shimpei

AU - Okamura, Takayuki

AU - Muramatsu, Takashi

AU - Ishibashi, Yuki

AU - Tateishi, Hiroki

AU - Miyazaki, Yosuke

AU - Asano, Taku

AU - Katagiri, Yuki

AU - von zur Muehlen, Constantin

AU - Tanabe, Kengo

AU - Kozuma, Ken

AU - Ozaki, Yukio

AU - Serruys, Patrick W.

AU - Onuma, Yoshinobu

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Vascular reparative therapy has become a reality with bioresorbable scaffolds (BRSs). To assess acute and long-term performance of the device, multimodality imaging would be essential. Radiopacity of metal hinders the imaging assessment, whereas radiolucent polymeric scaffolds allow for a precise imaging assessment with either invasive or non-invasive modality at baseline and at follow-up, which is one of the advantages of polymeric BRSs. Recent large trials evaluating clinical results of the first-generation BRS technology raised concerns about the safety and efficacy of these devices, namely, scaffold thrombosis. Intensive research with multimodality imaging in the field is being conducted to have in-depth understanding of the issues, which will facilitate the improvement of implantation techniques and the development of the next-generation BRSs. The current review focuses on the clinical application of the imaging modalities to assess the short- and long-term performance of the Absorb BVS.

AB - Vascular reparative therapy has become a reality with bioresorbable scaffolds (BRSs). To assess acute and long-term performance of the device, multimodality imaging would be essential. Radiopacity of metal hinders the imaging assessment, whereas radiolucent polymeric scaffolds allow for a precise imaging assessment with either invasive or non-invasive modality at baseline and at follow-up, which is one of the advantages of polymeric BRSs. Recent large trials evaluating clinical results of the first-generation BRS technology raised concerns about the safety and efficacy of these devices, namely, scaffold thrombosis. Intensive research with multimodality imaging in the field is being conducted to have in-depth understanding of the issues, which will facilitate the improvement of implantation techniques and the development of the next-generation BRSs. The current review focuses on the clinical application of the imaging modalities to assess the short- and long-term performance of the Absorb BVS.

UR - http://www.scopus.com/inward/record.url?scp=85040030161&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85040030161&partnerID=8YFLogxK

U2 - 10.1007/s12928-017-0486-5

DO - 10.1007/s12928-017-0486-5

M3 - Review article

C2 - 28766253

AN - SCOPUS:85040030161

SN - 1868-4300

VL - 33

SP - 11

EP - 22

JO - Cardiovascular Intervention and Therapeutics

JF - Cardiovascular Intervention and Therapeutics

IS - 1

ER -

Imaging assessment of bioresorbable vascular scaffolds

Abstract

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Fingerprint

Cite this